Patents by Inventor Amy Dix Rock
Amy Dix Rock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9931311Abstract: Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.Type: GrantFiled: April 11, 2017Date of Patent: April 3, 2018Assignee: Cumberland Pharmaceuticals Inc.Inventors: Leo Pavliv, Amy Dix Rock
-
Publication number: 20170273925Abstract: An effective dose of intravenous ibuprofen administered co-adminstered with intravenous acetaminophen in surgery patients is a safe and effective way to reduce both pain and the need for opioid analgesics. In preferred embodiments, the administration of intravenous ibuprofen and intravenous acetaminophen starts no later than at approximately the completion of wound closure.Type: ApplicationFiled: June 13, 2017Publication date: September 28, 2017Applicant: Cumberland Pharmaceuticals Inc.Inventors: Leo Pavliv, Amy Dix Rock
-
Publication number: 20170216232Abstract: Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.Type: ApplicationFiled: April 11, 2017Publication date: August 3, 2017Applicant: Cumberland Pharmaceuticals Inc.Inventors: Leo Pavliv, Amy Dix Rock
-
Patent number: 9649284Abstract: Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.Type: GrantFiled: August 13, 2015Date of Patent: May 16, 2017Assignee: Cumberland Pharmaceuticals, Inc.Inventors: Leo Pavliv, Amy Dix Rock
-
Publication number: 20160113894Abstract: Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.Type: ApplicationFiled: August 13, 2015Publication date: April 28, 2016Inventors: Leo PAVLIV, Amy Dix Rock
-
Publication number: 20160095830Abstract: An effective dose of intravenous ibuprofen administered co-adminstered with intravenous acetaminophen in surgery patients is a safe and effective way to reduce both pain and the need for opioid analgesics. In preferred embodiments, the administration of intravenous ibuprofen and intravenous acetaminophen starts no later than at approximately the completion of wound closure.Type: ApplicationFiled: October 5, 2015Publication date: April 7, 2016Applicant: Cumberland Pharmaceuticals Inc.Inventors: Leo PAVLIV, Amy Dix ROCK
-
Patent number: 9295639Abstract: Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.Type: GrantFiled: July 6, 2010Date of Patent: March 29, 2016Assignee: Cumberland Pharmaceuticals Inc.Inventors: Leo Pavliv, Amy Dix Rock
-
Patent number: 9138404Abstract: Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.Type: GrantFiled: October 6, 2014Date of Patent: September 22, 2015Assignee: Cumberland Pharmaceuticals Inc.Inventors: Leo Pavliv, Amy Dix Rock
-
Patent number: 9114068Abstract: Methods of treating a patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen in an amount effective to treat at least one condition in the patient chosen from pain, inflammation, and fever and to provide a clinically relevant effect on mean arterial pressure of the patients during the dosage interval comprising no increase or no statistically significant increase in mean arterial pressure.Type: GrantFiled: April 29, 2014Date of Patent: August 25, 2015Assignee: Cumberland Pharmaceuticals, Inc.Inventors: Leo Pavliv, Amy Dix Rock
-
Publication number: 20150087710Abstract: Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.Type: ApplicationFiled: October 6, 2014Publication date: March 26, 2015Inventors: Leo Pavliv, Amy Dix Rock
-
Patent number: 8871810Abstract: Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.Type: GrantFiled: December 23, 2009Date of Patent: October 28, 2014Assignee: Cumberland Pharmaceuticals Inc.Inventors: Leo Pavliv, Amy Dix Rock
-
Publication number: 20140235720Abstract: Methods of treating a patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen in an amount effective to treat at least one condition in the patient chosen from pain, inflammation, and fever and to provide a clinically relevant effect on mean arterial pressure of the patients during the dosage interval comprising no increase or no statistically significant increase in mean arterial pressure.Type: ApplicationFiled: April 29, 2014Publication date: August 21, 2014Applicant: Cumberland Pharmaceuticals Inc.Inventors: Leo Pavliv, Amy Dix Rock
-
Patent number: 8735452Abstract: Methods of treating a patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen in an amount effective to treat at least one condition in the patient chosen from pain, inflammation, and fever and to provide a clinically relevant effect on mean arterial pressure of the patients during the dosage interval comprising no increase or no statistically significant increase in mean arterial pressure.Type: GrantFiled: February 3, 2010Date of Patent: May 27, 2014Assignee: Cumberland Pharmaceuticals Inc.Inventors: Leo Pavliv, Amy Dix Rock
-
Publication number: 20130190403Abstract: A method for treating human patients who require hospitalization for a trauma injury wherein the patients are intravenously administered a first dose of a therapeutically effective dose of ibuprofen intravenously as soon as possible after hospitalization is disclosed. The patients are further treated with intravenous ibuprofen at suitable dosing intervals to the human patient until (a) the patient no longer requires intravenous dosing of ibuprofen.Type: ApplicationFiled: January 23, 2012Publication date: July 25, 2013Applicant: Cumberland Pharmaceuticals Inc.Inventors: Leo Pavliv, Amy Dix Rock
-
Publication number: 20110028553Abstract: Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.Type: ApplicationFiled: December 23, 2009Publication date: February 3, 2011Applicant: Cumberland Pharmaceuticals Inc.Inventors: Leo PAVLIV, Amy Dix Rock
-
Publication number: 20110028558Abstract: Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.Type: ApplicationFiled: July 6, 2010Publication date: February 3, 2011Applicant: Cumberland Pharmaceuticals Inc.Inventors: Leo PAVLIV, Amy Dix Rock
-
Publication number: 20110028557Abstract: Methods of treating a patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen in an amount effective to treat at least one condition in the patient chosen from pain, inflammation, and fever and to provide a clinically relevant effect on mean arterial pressure of the patients during the dosage interval comprising no increase or no statistically significant increase in mean arterial pressure.Type: ApplicationFiled: February 3, 2010Publication date: February 3, 2011Applicant: Cumberland Pharmaceuticals Inc.Inventors: LEO PAVLIV, Amy Dix Rock